Rocket Lab’s Q3 2026 results, released November 9, drove sharp volatility in RKLB shares during the week of November 9. Revenue reached a record $267.8 million, up 73% year-over-year and above consensus, while backlog expanded 52% sequentially to $3.57 billion on more than $515 million in new Neutron contracts priced at $70 million per launch. The wider-than-expected GAAP loss and lack of a firm 2027 first-flight date triggered an initial sell-off after pre-earnings gains, pushing the stock from a November 5 low near $44 to intraday peaks above $68 before settling around $60–64. First positive GAAP operating cash flow and the upcoming 100th Electron launch on November 14 provide near-term support, though multiple analyst price-target reductions highlight execution risks ahead of Neutron’s debut.